Results 111 to 120 of about 4,708 (180)

Factors that influence the utilisation of ototoxicity monitoring services for patients on treatment for drug-resistant tuberculosis

, 2015
Multi-drug resistance is increasingly becoming a challenge to tuberculosis control programmes globally. Treatment of multi-drug resistance tuberculosis (MDR-TB) includes aminoglycoside antibiotics which are known to cause hearing loss.
Nhokwara, Primrose Tinashe
core  

Cancer therapy-induced ototoxicity: Current challenges and emerging management strategies. [PDF]

Animal Model Exp Med
Huang Y, Xu B, Chen X, Chen Y, Yu D.
europepmc   +1 more source

Progressive Sensorineural Hearing Loss Following Cisplatin Chemotherapy: Mechanisms Underlying Cochlear Retention and Long-Term Ototoxicity. [PDF]

Pharmaceuticals (Basel)
Ruggiero A, Picciotti PM, Mastrangelo S, Romano A, Talloa D, Galli J, Attinà G.   +6 more
europepmc   +1 more source

Early Detection of Ototoxicity Using Serial Mobile Audiometry, Otoacoustic Emissions Testing, and Inner Ear Biomarker Measurement in Patients Receiving Platinum-Based Chemotherapy Treatment: It is Feasible to Implement in a National Health Service (NHS) Cancer Ambulatory Care Setting. [PDF]

Otol Neurotol
Mehta N, Awad A, Forbes M, Iliadou E, Katiri R, Ferdous T, Lowe H, Ensell L, Alifrangis C, Schilder AGM, Windsor R.   +10 more
europepmc   +1 more source

Identifying Gaps and Opportunities to Improve Ototoxicity Management in Veterans With Cancer: Evidence From a Retrospective Cohort and Oncology Provider Survey. [PDF]

Cancer Med
Lacey C, Clark K, Debacker JR, Stuehm H, Hungerford M, Milnes T, Johansson K, Mannino R, Graff JN, Konrad-Martin D.   +9 more
europepmc   +1 more source

Hearing Loss in Systemic Lupus Erythematosus: a Systematic Review. [PDF]

Maedica (Bucur)
Hanna Y, Tlais M, Natour D, Mazraani Y, Obeid N, Sarraf G, Zalzali I, Moghnie Y, Harouny T, Chebbo H, Farhat H.   +10 more
europepmc   +1 more source

The synergistic ototoxicity of adalimumab combined with methotrexate in the treatment of ankylosing spondylitis. [PDF]

Front Neurol
Wei H, Xu C.
europepmc   +1 more source

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain. [PDF]

IJTLD Open
Schiuma M, Piubello A, Saluzzo F, Cattaneo D, Salari F, Covizzi A, Rizzo A, Fama F, Ciubotariu C, Lombardi A, Antinori S, Riva A, Cirillo DM, Gori A, Torre A.   +14 more
europepmc   +1 more source

Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping. [PDF]

PLoS One
Macedo LT, Ferrari VE, Dias Costa EF, Lourenço GJ, Calonga L, Castilho AM, Chone CT, Passos Lima CS.   +7 more
europepmc   +1 more source

Rate of Hearing Loss in Platinum-Naïve Patients Receiving Immune Checkpoint Inhibitors. [PDF]

Otolaryngol Head Neck Surg
Brooks KA, Gidley CG, Grimley O, Wang C, Jivani S, Roberts D, Naing A, Phan J, Hutcheson K, Wang X, Gidley PW, Nader ME.   +11 more
europepmc   +1 more source